Skip to content
NETRIS Pharma logo

NETRIS Pharma Alternatives & Competitors

12 companies similar to NETRIS Pharma

Companies similar to NETRIS Pharma

XenTech logo — alternative to NETRIS Pharma

XenTech

Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 y...

Semafore Pharmaceuticals logo — alternative to NETRIS Pharma

Semafore Pharmaceuticals

Pioneering the future of cancer treatment with innovative PI3K inhibitors.

Nilogen Oncosystems logo — alternative to NETRIS Pharma

Nilogen Oncosystems

We analyze cancer drug responses using fresh patient tumor tissue with intact tumor microe...

Nanoligent logo — alternative to NETRIS Pharma

Nanoligent

Our mision is to improve the life of patients by designing new drugs that selectively targ...

Rival Readout

Competing with NETRIS Pharma? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Nirogy Therapeutics logo — alternative to NETRIS Pharma

Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...

Oncomedics logo — alternative to NETRIS Pharma

Oncomedics

1 patient - 1 tumour - 1 Oncogramme® - 1 treatment

Genus Oncology LLC logo — alternative to NETRIS Pharma

Genus Oncology LLC

Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...

Peptomyc logo — alternative to NETRIS Pharma

Peptomyc

Developing Peptides to treat Cancer

Sumitomo Pharma Oncology logo — alternative to NETRIS Pharma

Sumitomo Pharma Oncology

is part of Sumitomo Pharma America as of July 2023

BiPar Sciences logo — alternative to NETRIS Pharma

BiPar Sciences

Innovative therapies harnessing the power of PARP inhibitors to combat advanced cancers

Incyclix Bio logo — alternative to NETRIS Pharma

Incyclix Bio

Regaining Cell Cycle Control

SwaLife Biotech logo — alternative to NETRIS Pharma

SwaLife Biotech

SwaLife Biotech finds plant molecules for cosmetics and creates anticancer alkaloids targe...

About NETRIS Pharma

NETRIS Pharma is a biotechnology company based in France, focusing on the development of innovative cancer-fighting therapies. Established in 2008, the company has garnered attention due to its unique integration within the renowned Léon Bérard Cancer Center in Lyon, France. Their research is driven by a distinguished...

Services

Development of first-in-class therapeutics targeting Netrin-1 to overcome resistance in oncology

Target Customers

Patients with cancer, medical professionals, research institutions

Business keywords

Cancer Research, Pharmaceutical Industry, Therapeutic Molecules, Drug Development, Cellular Mechanisms, Léon Bérard Cancer Center, Dependence Receptors, Tumor Development, In Vitro Research, In Vivo Research, Preclinical Practices, Breast Cancer Treatment, Lung Cancer Treatment, Glioblastoma Treatment

Frequently Asked Questions

Companies similar to NETRIS Pharma include XenTech, Semafore Pharmaceuticals, Nilogen Oncosystems, Nanoligent, Nirogy Therapeutics. They work in Biotechnology and Health Care and share NETRIS Pharma's focus on drug development, cancer research and pharmaceutical industry.
Bounce Watch lists 12 companies that share NETRIS Pharma's industries and are closest to it in business tags, services, target customers, business model and size.
NETRIS Pharma is a biotechnology company based in France, focusing on the development of innovative cancer-fighting therapies. Established in 2008, the company has garnered attention due to its unique integration within the renowned Léon Bérard Cancer Center in Lyon, France. Their research is driven by a distinguished...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around NETRIS Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at NETRIS Pharma on 11 Jun 2025. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout